Evidence map›Paper›PMID 40948733›Full record

ArticlePatient preference and adherence2025

Content Validity of the Hemophilia Device Handling and Preference Assessment Questionnaire - A Cognitive Debrief Study in Patients with Hemophilia and Their Caregivers.

Niklas Kahr Rasmussen, Sanket Shah, Jui-Hua Tsai, Kelly P McCarrier, Emily A Hildebrand, Maya Gonczi, Gitte Ter-Borch, Birgitte Berg, Jesper Skov Neergaard

Abstract read
In one paragraph

Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Niklas Kahr RasmussenObesity and MASH, Novo Nordisk A/S, Søborg, Denmark.ORCID 0009-0005-0607-6617
Sanket ShahNovo Nordisk Inc., Plainsboro, New Jersey, USA.
Jui-Hua TsaiPatient Centered Outcomes, OPEN Health Group, Bethesda, Maryland, USA.
Kelly P McCarrierPatient Centered Outcomes, OPEN Health Group, Bethesda, Maryland, USA.
Emily A HildebrandResearch Collective LLC, Tempe, Arizona, USA.
Maya GoncziResearch Collective LLC, Tempe, Arizona, USA.
Gitte Ter-BorchClinical Operations, Novo Nordisk A/S, Søborg, Denmark.
Birgitte BergClinical Operations, Novo Nordisk A/S, Søborg, Denmark.
Jesper Skov NeergaardMedical & Science Innovation, Novo Nordisk A/S, Søborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: As new treatment options using different modes of administration become available for patients with hemophilia, it is important to assess how patients and caregivers perceive the use of different injection systems. Aim: This study aimed to evaluate patient comprehension, relevance, and comprehensiveness of the Methods: This cross-sectional interview study included participants randomly selected from a pen-injector handling and preference study in the USA who had self-administered a ten-item HDHPA questionnaire. Subsequently, semi-structured cognitive interviews were conducted examining HDHPA instrument instructions, items, and response options. Results: The study sample consisted of 20 participants (50% adult patients, 25% adolescents, and 25% caregivers; 75% male). Most participants (89-100%) demonstrated comprehension of the instructions given. Nearly all participants (94-100%) demonstrated clear comprehension of the ten HDHPA items. All 20 participants stated that the questionnaire was relevant and comprehensive in assessing the pen-injector and comparing it to their current device. Conclusion: The results of this study showed that the HDHPA items are comprehensible, relevant, and comprehensive, thereby confirming the content validity of this instrument.

Indexed as

content validityhemophiliapatient experiencepatient preferencequestionnaire design

Identifiers

PMID40948733
PMCPMC12433217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.